Want to join the conversation?
$CELG's sales from Pomalyst/Imnovid for 3Q15 jumped by 41.6% from last year, reflecting net sales of $150.1MM in the U.S. and $106.4MM in international markets. Increases in market share and treatment duration contributed to the increase in U.S. and international net sales of Pomalyst/Imnovid.
$DB is going to cut off services for about 3,400 clients in equities trading.
$F stock slid more than 2% after the company issued two safety recalls involving more than 650,000 Ford Fusion and Lincoln MKZ model cars.
The new CEO of $SBUX, Kevin Johnson, has some pretty large shoes to fill but there are many who have good faith in his ability to do so.
$TSLA opening a showroom in Michigan. A bold move !!